MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-022-25602-7

Медицинская библиотека · Scientific reports · 2022

Short course palliative radiotherapy in advanced solid tumors: a pooled analysis (the SHARON project).

Donati Costanza Maria, Macchia Gabriella, Siepe Giambattista, Zamagni Alice, Benini Anna, Cellini Francesco, Buwenge Milly, Cilla Savino, Cammelli Silvia, Rizzo Stefania, Caravatta Luciana, Wondemagegnhu Tigeneh, Uddin A F M Kamal, Deressa Biniyam Tefera, Sumon Mostafa A, Lodi Rizzini Elisa, Bazzocchi Alberto, Morganti Alessio G, Deodato Francesco, Farina Eleonora

СтатьяПеревод пока не подготовлен

Аннотация

Previous trials showed the tolerability and efficacy of a palliative radiotherapy (RT) regimen (SHARON) based on the 4 fractions delivered in 2 days in different oncological settings. In order to identify possible predictors of symptomatic response, the purpose of this study is to perform a pooled analysis of previous trials. We analyzed the impact on symptomatic response of the following parameters: tumor site, histological type, performance status (ECOG), dominant symptom, and RT dose using the Chi-square test and Fisher's exact test. One-hundred-eighty patients were analyzed. Median RT dose was 20 Gy (range: 14-20 Gy). The overall response rate was 88.8% (95% CI 83.3-92.7%) while pre- and post-treatment mean VAS was 5.3 (± 7.7) and 2.2 (± 2.2), respectively (p < 0.001). The overall response rate of pain, dyspnea, bleeding, dysphagia, and other symptoms was 86.2%, 90.9%, 100%, 87.5%, and 100%, respectively. Comparing the symptomatic effect based on the analyzed parameters no significant differences were recorded. However, patients with locally advanced disease showed a higher rate of symptomatic responses than metastatic ones (97.3% vs 83.0%; p = 0.021). Finally, the complete pain response rate was more than double in patients with mild to moderate (VAS: 4-7) compared to those with severe (VAS > 7) pain (36.0% vs 14.3%; p = 0.028). This pooled analysis showed high efficacy of the SHARON regimen in the relief of several cancer-related symptoms. The markedly and significantly higher complete pain response rate, in patients with mild-moderate pain, suggests early referral to palliative RT for patients with cancer-related pain.

Для цитирования: Donati Costanza Maria, Macchia Gabriella, Siepe Giambattista, Zamagni Alice, Benini Anna, Cellini Francesco, Buwenge Milly, Cilla Savino, Cammelli Silvia, Rizzo Stefania, Caravatta Luciana, Wondemagegnhu Tigeneh, Uddin A F M Kamal, Deressa Biniyam Tefera, Sumon Mostafa A, Lodi Rizzini Elisa, Bazzocchi Alberto, Morganti Alessio G, Deodato Francesco, Farina Eleonora. Short course palliative radiotherapy in advanced solid tumors: a pooled analysis (the SHARON project).. Scientific reports. 2022. DOI: 10.1038/s41598-022-25602-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.